Treatment De-escalation in AQP4-Ab Neuromyelitis Optica Spectrum Disorder

Affiliations

¹ From the Queen Square MS Centre (Y.L.), UCL Queen Square Institute of Neurology, Faculty of Brain Sciences, University College London, UK; Multiple Sclerosis Centre of Catalonia (C.T.), Neurology Department, Vall d'Hebron Barcelona Hospital Campus, Spain. yael@doctors.net.uk.
² From the Queen Square MS Centre (Y.L.), UCL Queen Square Institute of Neurology, Faculty of Brain Sciences, University College London, UK; Multiple Sclerosis Centre of Catalonia (C.T.), Neurology Department, Vall d'Hebron Barcelona Hospital Campus, Spain.

Editorial

Yael Hacohen et al. Neurology. 2023.

. 2023 Jul 25;101(4):153-154.

doi: 10.1212/WNL.0000000000207521. Epub 2023 Jun 13.

¹ From the Queen Square MS Centre (Y.L.), UCL Queen Square Institute of Neurology, Faculty of Brain Sciences, University College London, UK; Multiple Sclerosis Centre of Catalonia (C.T.), Neurology Department, Vall d'Hebron Barcelona Hospital Campus, Spain. yael@doctors.net.uk.
² From the Queen Square MS Centre (Y.L.), UCL Queen Square Institute of Neurology, Faculty of Brain Sciences, University College London, UK; Multiple Sclerosis Centre of Catalonia (C.T.), Neurology Department, Vall d'Hebron Barcelona Hospital Campus, Spain.

No abstract available

Comment on

Rituximab De-escalation in Patients With Neuromyelitis Optica Spectrum Disorder.
Demuth S, Collongues N, Audoin B, Ayrignac X, Bourre B, Ciron J, Cohen M, Deschamps R, Durand-Dubief F, Maillart E, Papeix C, Ruet A, Zephir H, Marignier R, De Seze J; NOMADMUS Study Group. Demuth S, et al. Neurology. 2023 Jul 25;101(4):e438-e450. doi: 10.1212/WNL.0000000000207443. Epub 2023 Jun 8. Neurology. 2023. PMID: 37290967 Free PMC article.